MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma.
about
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithmsPrognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalC-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studiesGenetic lesions in diffuse large B-cell lymphomasDoes cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with diffuse large B-cell lymphoma treated with rituximab and chemotherapy? A systematic review.MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphomaThe impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.Interpreting MYC and BCL2 in diffuse large B-cell lymphoma.MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection.
P2860
Q34617849-E47B5FBE-1E71-4898-9AF6-67A3C1D446B5Q34882773-E8B9ACC7-475A-45B0-855E-2A3BD2065DBCQ34918948-31155D60-C193-491F-B6F9-94A9150513B7Q35150618-057E0803-27AE-4914-B698-5BDB5D43655DQ35974341-E999A2F4-7B13-4C20-8D2B-D45B54DBADE0Q36302961-A2837286-1C5F-4AC3-A740-2B4EE8E64FD0Q37142412-87EBD3B7-CDDC-4660-8D77-5CB7665FE5DDQ38124735-FE545B15-F86C-4EC4-89C4-89E0D2CA8CFFQ38376595-1A5CE326-15EF-4CBC-9DC7-A0C89E19F618Q38975357-31C9A2C6-7F45-4493-9077-9340E345557BQ43477729-2F0628CB-3AEC-4D4B-8363-FA2A30F357F6Q45323747-D6150E5F-FD07-418D-836A-42762E2B9C6D
P2860
MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@en
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@nl
type
label
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@en
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@nl
prefLabel
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@en
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P1433
P1476
MYC rearrangements are useful ...... diffuse large B-cell lymphoma.
@en
P2093
Hidekazu Nishikii
Jun Takizawa
Kiyoshi Ando
Masayuki Noguchi
Minoru Kojima
Naoya Nakamura
Sadao Aoki
Shigeru Chiba
P2860
P304
P356
10.3109/10428194.2013.771398
P577
2013-03-08T00:00:00Z